Simplex Trading’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.51M | Sell |
180,300
-88,300
| -33% | -$805K | ﹤0.01% | 2319 |
|
|
2026
Q1 | $2.42M | Buy |
268,600
+47,700
| +22% | +$753K | ﹤0.01% | 1674 |
|
|
2025
Q4 | $4.03M | Buy |
220,900
+87,000
| +65% | +$1.47M | ﹤0.01% | 1451 |
|
|
2025
Q3 | $1.96M | Sell |
133,900
-5,100
| -4% | -$87.4K | ﹤0.01% | 2345 |
|
|
2025
Q2 | $2.53M | Buy |
139,000
+500
| +0.4% | +$10.2K | ﹤0.01% | 1902 |
|
|
2025
Q1 | $2.75M | Sell |
138,500
-8,200
| -6% | -$142K | ﹤0.01% | 1743 |
|
|
2024
Q4 | $2.52M | Sell |
146,700
-17,300
| -11% | -$325K | ﹤0.01% | 1999 |
|
|
2024
Q3 | $3.28M | Sell |
164,000
-35,700
| -18% | -$555K | ﹤0.01% | 1847 |
|
|
2024
Q2 | $2.23M | Buy |
199,700
+77,800
| +64% | +$653K | ﹤0.01% | 2092 |
|
|
2024
Q1 | $804K | Buy |
121,900
+88,800
| +268% | +$485K | ﹤0.01% | 3352 |
|
|
2023
Q4 | $149K | Buy |
33,100
+25,600
| +341% | +$94.7K | ﹤0.01% | 4981 |
|
|
2023
Q3 | $26K | Sell |
7,500
-114,200
| -94% | -$440K | ﹤0.01% | 6375 |
|
|
2023
Q2 | $449K | Sell |
121,700
-146,800
| -55% | -$544K | ﹤0.01% | 3423 |
|
|
2023
Q1 | $888K | Sell |
268,500
-73,100
| -21% | -$253K | ﹤0.01% | 2697 |
|
|
2022
Q4 | $1.32M | Buy |
341,600
+72,800
| +27% | +$225K | ﹤0.01% | 2204 |
|
|
2022
Q3 | $653K | Buy |
268,800
+160,200
| +148% | +$384K | ﹤0.01% | 3148 |
|
|
2022
Q2 | $215K | Buy |
108,600
+47,000
| +76% | +$92.5K | ﹤0.01% | 4511 |
|
|
2022
Q1 | $112K | Sell |
61,600
-19,500
| -24% | -$30.4K | ﹤0.01% | 5980 |
|
|
2021
Q4 | $114K | Buy |
81,100
+21,500
| +36% | +$28.3K | ﹤0.01% | 6038 |
|
|
2021
Q3 | $94K | Sell |
59,600
-100
| -0.2% | -$140 | ﹤0.01% | 6701 |
|
|
2021
Q2 | $95K | Buy |
59,700
+58,977
| +8,157% | +$104K | ﹤0.01% | 6795 |
|
|
2021
Q1 | $127K | Sell |
723
-730
| -50% | -$1.67K | ﹤0.01% | 5407 |
|
|
2020
Q4 | $283K | Buy |
1,453
+1,115
| +330% | +$2.34K | ﹤0.01% | 4155 |
|
|
2020
Q3 | $80K | Sell |
338
-375
| -53% | -$1.03K | ﹤0.01% | 5130 |
|
|
2020
Q2 | $208K | Sell |
713
-1,721
| -71% | -$4.94K | ﹤0.01% | 3948 |
|
|
2020
Q1 | $700K | Buy |
2,434
+2,418
| +15,113% | +$8.36K | ﹤0.01% | 2245 |
|
|
2019
Q4 | $6K | Sell |
16
-385
| -96% | -$1.68K | ﹤0.01% | 6597 |
|
|
2019
Q3 | $178K | Buy |
401
+267
| +199% | +$1.12K | ﹤0.01% | 3682 |
|
|
2019
Q2 | $51K | Buy |
134
+16
| +14% | +$71 | ﹤0.01% | 4842 |
|
|
2019
Q1 | $44K | Buy |
+118
| New | +$417 | ﹤0.01% | 5105 |
|
Other funds holding ADMA
Simplex Trading's ADMA Position: Q2 2026 in Review
Simplex Trading reduced its ADMA Biologics (ADMA) stake by 49% in Q2 2026, selling an estimated $247K and leaving 27,876 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.
Simplex Trading first reported a position in ADMA in Q3 2018 and has held it in 17 quarters since. The position peaked at $774K in Q3 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.
- Simplex Trading held 27,876 shares of ADMA Biologics worth $233K as of Q2 2026.
- Simplex Trading sold 27,041 ADMA Biologics shares in Q2 2026, an estimated $247K.
- ADMA Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4514 holding.
- Simplex Trading first reported a position in ADMA Biologics in Q3 2018 and has held it in 17 quarters since.
- Simplex Trading's ADMA Biologics position peaked at $774K in Q3 2025.
- 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.